HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Radiosensitization of cancer cells by hydroxychalcones.

Abstract
Radiation sensitization is significantly increased by proteotoxic stress, such as a heat shock. We undertook an investigation, seeking to identify natural products that induced proteotoxic stress and then determined if a compound exhibited radiosensitizing properties. The hydroxychalcones, 2',5'-dihydroxychalcone (D-601) and 2,2'-dihydroxychalcone (D-501), were found to activate heat shock factor 1 (Hsf1) and exhibited radiation sensitization properties in colon and pancreatic cancer cells. The radiosensitization ability of D-601 was blocked by pretreatment with α-napthoflavone (ANF), a specific inhibitor of cytochrome P450 1A2 (CYP1A2), suggesting that the metabolite of D-601 is essential for radiosensitization. The study demonstrated the ability of hydroxychalcones to radiosensitize cancer cells and provides new leads for developing novel radiation sensitizers.
AuthorsRory Pruitt, Nidhish Sasi, Michael L Freeman, Konjeti R Sekhar
JournalBioorganic & medicinal chemistry letters (Bioorg Med Chem Lett) Vol. 20 Issue 20 Pg. 5997-6000 (Oct 15 2010) ISSN: 1464-3405 [Electronic] England
PMID20826087 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
CopyrightCopyright © 2010 Elsevier Ltd. All rights reserved.
Chemical References
  • 2',5'-dihydroxychalcone
  • 2,2'-dihydroxychalcone
  • Chalcones
  • Radiation-Sensitizing Agents
Topics
  • Adenocarcinoma (radiotherapy)
  • Cell Line, Tumor
  • Chalcones (pharmacology)
  • Colonic Neoplasms (radiotherapy)
  • Humans
  • Pancreatic Neoplasms (radiotherapy)
  • Radiation-Sensitizing Agents (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: